About Toxiven
Toxiven is a Healthcare company based in India founded in 2019. Pioneering reliable tools for snakebite venom detection and treatment worldwide. It operates on a B2B model. The company has 28 employees. Its Indian entity Toxiven Biotech Private Limited reported revenue of ₹1.17 Cr. Toxiven offers products and services including Venom Detection Kit and Diagnostic Tools. Its focus areas include Biotech, Therapeutics, Venom Detection and Diagnostics.
Company details
ToxiVen specializes in biotechnology for snakebite diagnostics, creating cutting-edge tools for rapid venom detection to support clinical management and save lives. Based in India, the company equips healthcare providers globally with essential solutions, reducing socio-economic impacts in rural areas through innovation and patented technologies. Their activities include developing diagnostic kits and advancing treatment methods.
- Headquarters India
- Employees 28
- SectorsHealthcare
- Email••••••••
- Website toxiven.com
- Social LinkedIn Facebook Instagram
- Legal Name Toxiven Biotech Private Limited
- Date of Incorporation 28 Feb, 2019
- Jurisdiction Coimbatore, Tamil Nadu, India
- Annual Revenue₹1.17 Cr
FY 2026 · -33% YoY
- Net Profit₹30 Lakh
FY 2026 · 26% margin
- EBITDA₹58.4 Lakh
FY 2026 · 50% margin
- Employee Count28
Associated legal entities of Toxiven
Toxiven operates through Toxiven Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Toxiven Biotech Private Limited CIN U24304TZ2019PTC031781 | Active | 28 Feb 2019 | Pollachi, Tamil Nadu | ₹1.2 Cr | 18 | 4 | View details |
Products & Services of Toxiven
Toxiven offers a comprehensive portfolio of products and services, including Venom Detection Kit and Diagnostic Tools.
Tools for rapid and accurate snakebite venom identification in clinical settings
Solutions supporting snakebite treatment and management for healthcare providers
Board of directors of Toxiven Biotech Private Limited (Toxiven)
Toxiven Biotech Private Limited is the primary company behind Toxiven. The board of Toxiven Biotech Private Limited currently have 4 directors; the longest-serving is Harry Fonseca Williams, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harry Fonseca Williams DIN 08394353 | Director | 20 Mar 2019 | 7 yrs 7 mo | Toxiven Biotech Private Limited |
| Arumugam Sundhararajan DIN 10392029 | Director | 22 Nov 2023 | 2 yrs 11 mo | Toxiven Biotech Private Limited |
| Mohanraj Vaiyapuri DIN 10827704 | Director | 25 Nov 2024 | 1 yr 11 mo | Toxiven Biotech Private Limited |
| Padmini Ramachandran DIN 10832319 | Director | 25 Nov 2024 | 1 yr 11 mo | Toxiven Biotech Private Limited |
Financials of Toxiven
Figures of Toxiven Biotech Private Limited, the primary company behind Toxiven, for FY 2026. Revenue was ₹1.17 Cr (-33% year on year). Net profit was ₹30 Lakh (26% margin). EBITDA was ₹58.4 Lakh (50% margin). Revenue has grown at a compounded annual rate of +49% over three years and +34% over five years.
- ₹1.17 CrRevenue · FY 2026 · -33% YoY
- ₹30 LakhNet profit · 26% margin
- ₹58.4 LakhEBITDA · 50% margin
- ₹3,437Paid-up capital
- 18Employees (provident fund records)
- +49%Revenue CAGR, 3 years
- +34%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Toxiven Biotech Private Limited are on its company page.
Detailed financial statements for Toxiven
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Toxiven
Toxiven was founded in 2019.
Toxiven is headquartered in India.
Toxiven has 28 employees.
The primary company behind Toxiven, Toxiven Biotech Private Limited, reported revenue of ₹1.17 Cr for FY 2026, down 33% year on year.
ToxiVen specializes in biotechnology for snakebite diagnostics, creating cutting-edge tools for rapid venom detection to support clinical management and save lives. Based in India, the company equips healthcare providers globally with essential solutions, reducing socio-economic impacts in rural areas through innovation and patented technologies. Their activities include developing diagnostic kits and advancing treatment methods.
Toxiven offers Venom Detection Kit and Diagnostic Tools.
Toxiven operates through Toxiven Biotech Private Limited.
The legal entities of Toxiven currently have 4 directors, including Arumugam Sundhararajan, Harry Fonseca Williams, Mohanraj Vaiyapuri and others.